News Releases
Featured News
NIH grant supports KU study of DNA-protein cross-links
Identifying toxic DNA-protein cross-links (DPCs) and the cellular pathways to repair them are the goals of research underway by University of Kansas researcher Luke Erber, assistant professor of medicinal chemistry, and his lab team. The research is being funded by a $1.8 million grant recently announced by the National Institute of General Medical Sciences, a unit of the National Institutes of Health.
More News
Mon, 12/01/2025
Identifying toxic DNA-protein cross-links (DPCs) and the cellular pathways to repair them are the goals of research underway by University of Kansas researcher Luke Erber, assistant professor of medicinal chemistry, and his lab team. The research is being funded by a $1.8 million grant recently announced by the National Institute of General Medical Sciences, a unit of the National Institutes of Health.
Mon, 12/01/2025
School of Pharmacy researcher and associate professor of pharmacology and toxicology Zijun Wang was recently published in Nature Communications. Her research delves into social isolation and how it impacts mental health and substance abuse disorders and potentially discovering drug therapies to intervene.
Thu, 10/02/2025
Mira Shenoy is one of two KU Pharmacy grads participating in the prestigious Rutgers Pharmaceutical Industry Fellowship Program. She shares her experience as a Fellow and her perspectives of how the KU School of Pharmacy was essential in preparing her for career success.
Mon, 09/22/2025
The Spotlight on Faculty Excellence recognizes faculty contributions in research, scholarship and creative activity. Each honoree is recognized during a KU Athletics event.
Fri, 09/19/2025
Her goal of a college degree was delayed more than 20 years, but that has not kept Sarah Kennedy, a mother and grandmother, from turning her dreams into reality. She is a first-year pharmacy student at KU with her eye on the prize of a Pharm.D. degree.